Literature DB >> 26273108

Generating Charged Pharmaceutical Aerosols Intended to Improve Targeted Drug Delivery in Ventilated Infants.

Landon Holbrook1, Michael Hindle2, P Worth Longest3.   

Abstract

The delivery of pharmaceutical aerosols to infants receiving mechanical ventilation is extremely challenging due to small diameter flow passages, low tidal volumes, and frequent exhalation of the aerosol. The use of small charged particles is proposed as a novel method to prevent deposition in ventilator components and foster deposition in the lower infant airways. The objective of this study was to compare the performance of multiple new devices for generating small charged particles that are expected to maximize respiratory drug delivery in ventilated infants. Criteria used to select a leading device included production of a charged aerosol with a mass median aerodynamic diameter (MMAD) ≤ approximately 1.8 μm; low device depositional loss of the aerosol (<20%); particle charge in the range of the Rayleigh limit/100; and high drug output with low performance variability. Proposed new devices were a wick electrospray (WES) system with accelerated cross-flow air; a condensational vapor (CV) system with a charged solution and strong field gradient; and a low flow - induction charger (LF-IC) designed to operate with a modified commercial mesh nebulizer. Based on infant ventilation conditions, flow rates through the devices were in a range of 2-5 L/min and the devices were assessed in terms of depositional drug loss and emitted drug mass; droplet size distribution (DSD) using a Mini-MOUDI; and DSD and net charge with a modified ELPI. Considering the WES, primary limitations were (i) low and variable aerosol production rates and (ii) high device depositional losses. The CV device produced a high quality aerosol with a MMAD of 0.14 μm and a drug delivery rate of 25 μg/min. However, the device was excluded because it failed to produce a charged aerosol. In contrast, the LF-IC produced a 1.6 μm aerosol with high net charge, low device depositional loss (<15% based on recovery), and low variability. In the ELPI size fraction bin nearest the MMAD, the LF-IC produced >100 elementary charges per particle, which was an order of magnitude increase compared to the case of zero charging voltage. In conclusion, the LF-IC was selected as a leading system that is expected to improve aerosol delivery efficiency in ventilated infants through the use of small charged particles.

Entities:  

Keywords:  condensational aerosol generator; induction charger; infants; mechanical ventilation; mesh nebulizer; respiratory drug delivery; wick electrospray

Year:  2015        PMID: 26273108      PMCID: PMC4530998          DOI: 10.1016/j.jaerosci.2015.05.015

Source DB:  PubMed          Journal:  J Aerosol Sci        ISSN: 0021-8502            Impact factor:   3.433


  32 in total

1.  Effects of oral airway geometry characteristics on the diffusional deposition of inhaled nanoparticles.

Authors:  Jinxiang Xi; P Worth Longest
Journal:  J Biomech Eng       Date:  2008-02       Impact factor: 2.097

2.  Quantitative analysis and design of a spray aerosol inhaler. Part 2: improvements in mouthpiece performance.

Authors:  Michael Hindle; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-10-25       Impact factor: 2.849

3.  Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.

Authors:  C H Cole; T Colton; B L Shah; S Abbasi; B L MacKinnon; S Demissie; I D Frantz
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

4.  Aerosol deposition in neonatal ventilation.

Authors:  Jean C Dubus; Laurent Vecellio; Michele De Monte; James B Fink; Daniel Grimbert; Jerome Montharu; Chantal Valat; Neil Behan; Patrice Diot
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

Review 5.  Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.

Authors:  L P Brion; R A Primhak; W Yong
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

6.  Effect of energy on propylene glycol aerosols using the capillary aerosol generator.

Authors:  X Shen; M Hindle; P R Byron
Journal:  Int J Pharm       Date:  2004-05-04       Impact factor: 5.875

7.  Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.

Authors:  Anne-Laure Sidler-Moix; Ugo Dolci; Markoulina Berger-Gryllaki; André Pannatier; Jacques Cotting; Ermindo R Di Paolo
Journal:  Pediatr Crit Care Med       Date:  2013-02       Impact factor: 3.624

Review 8.  Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

Authors:  V Shah; A Ohlsson; H L Halliday; M S Dunn
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  Aerosolized albuterol sulfate delivery under neonatal ventilatory conditions: in vitro evaluation of a novel ventilator circuit patient interface connector.

Authors:  Jan Mazela; Krzysztof Chmura; Maksymilian Kulza; Christopher Henderson; Timothy J Gregory; Arkadiusz Moskal; Tomasz R Sosnowski; Ewa Florek; Lucyna Kramer; Martin Keszler
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-03-19       Impact factor: 2.849

Review 10.  Aerosol delivery to ventilated infant and pediatric patients.

Authors:  James B Fink
Journal:  Respir Care       Date:  2004-06       Impact factor: 2.258

View more
  3 in total

Review 1.  Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.

Authors:  Worth Longest; Benjamin Spence; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-07-09       Impact factor: 2.849

2.  In Vitro Assessment of Small Charged Pharmaceutical Aerosols in a Model of a Ventilated Neonate.

Authors:  Landon Holbrook; Michael Hindle; P Worth Longest
Journal:  J Aerosol Sci       Date:  2017-05-13       Impact factor: 3.433

3.  In Vitro Determination of the Main Effects in the Design of High-Flow Nasal Therapy Systems with Respect to Aerosol Performance.

Authors:  Gavin Bennett; Mary Joyce; Louise Sweeney; Ronan MacLoughlin
Journal:  Pulm Ther       Date:  2018-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.